All-cause and cause-specific mortality among people with severe mental illness in Brazil's public health system, 2000-15: a retrospective study.


Journal

The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123

Informations de publication

Date de publication:
10 2022
Historique:
received: 22 02 2022
revised: 19 05 2022
accepted: 24 06 2022
pubmed: 15 8 2022
medline: 21 9 2022
entrez: 14 8 2022
Statut: ppublish

Résumé

People with severe mental illness have a mortality rate higher than the general population, living an average of 10-20 years less. Most studies of mortality among people with severe mental illness have occurred in high-income countries (HICs). We aimed to estimate all-cause and cause-specific relative risk (RR) and excess mortality rate (EMR) in a nationwide cohort of inpatients with severe mental illness compared with inpatients without severe mental illness in a middle income country, Brazil. This national retrospective cohort study included all patients hospitalised through the Brazilian Public Health System (Sistema Único de Saúde [SUS]-Brazil) between Jan 1, 2000, and April 21, 2015. Probabilistic and deterministic record linkages integrated data from the Hospital Information System (Sistema de informações Hospitalares) and the National Mortality System (Sistema de Informação sobre Mortalidade). Follow-up duration was measured from the date of the patients' first hospitalisation until their death, or until April 21, 2015. Severe mental illness was defined as schizophrenia, bipolar disorder, or depressive disorder by ICD-10 codes used for the admission. RR and EMR were calculated with 95% CIs, comparing mortality among patients with severe mental illness with those with other diagnoses for patients aged 15 years and older. We redistributed deaths using the Global Burden of Diseases, Injuries, and Risk Factors Study methodology if ill-defined causes of death were stated as an underlying cause. From Jan 1, 2000, to April 21, 2015, 72 021 918 patients (31 510 035 [43·8%] recorded as male and 40 974 426 [56·9%] recorded as female; mean age 41·1 (SD 23·8) years) were admitted to hospital, with 749 720 patients (372 458 [49·7%] recorded as male and 378 670 [50·5%] as female) with severe mental illness. 5 102 055 patient deaths (2 862 383 [56·1%] recorded as male and 2 314 781 [45·4%] as female) and 67 485 deaths in patients with severe mental illness (39 099 [57·9%] recorded as male and 28 534 [42·3%] as female) were registered. The RR for all-cause mortality in patients with severe mental illness was 1·27 (95% CI 1·27-1·28) and the EMR was 2·52 (2·44-2·61) compared with non-psychiatric inpatients during the follow-up period. The all-cause RR was higher for females and for younger age groups; however, EMR was higher in those aged 30-59 years. The RR and EMR varied across the leading causes of death, sex, and age groups. We identified injuries (suicide, interpersonal violence, and road injuries) and cardiovascular disease (ischaemic heart disease) as having the highest EMR among those with severe mental illness. Data on ethnicity were not available. In contrast to studies from HICs, inpatients with severe mental illness in Brazil had high RR for idiopathic epilepsy, tuberculosis, HIV, and acute hepatitis, and no significant difference in mortality from cancer compared with inpatients without severe mental illness. These identified causes should be addressed as a priority to maximise mortality prevention among people with severe mental illness, especially in a middle-income country like Brazil that has low investment in mental health. Bill and Melinda Gates Foundation, Fundação de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG, and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil.

Sections du résumé

BACKGROUND
People with severe mental illness have a mortality rate higher than the general population, living an average of 10-20 years less. Most studies of mortality among people with severe mental illness have occurred in high-income countries (HICs). We aimed to estimate all-cause and cause-specific relative risk (RR) and excess mortality rate (EMR) in a nationwide cohort of inpatients with severe mental illness compared with inpatients without severe mental illness in a middle income country, Brazil.
METHODS
This national retrospective cohort study included all patients hospitalised through the Brazilian Public Health System (Sistema Único de Saúde [SUS]-Brazil) between Jan 1, 2000, and April 21, 2015. Probabilistic and deterministic record linkages integrated data from the Hospital Information System (Sistema de informações Hospitalares) and the National Mortality System (Sistema de Informação sobre Mortalidade). Follow-up duration was measured from the date of the patients' first hospitalisation until their death, or until April 21, 2015. Severe mental illness was defined as schizophrenia, bipolar disorder, or depressive disorder by ICD-10 codes used for the admission. RR and EMR were calculated with 95% CIs, comparing mortality among patients with severe mental illness with those with other diagnoses for patients aged 15 years and older. We redistributed deaths using the Global Burden of Diseases, Injuries, and Risk Factors Study methodology if ill-defined causes of death were stated as an underlying cause.
FINDINGS
From Jan 1, 2000, to April 21, 2015, 72 021 918 patients (31 510 035 [43·8%] recorded as male and 40 974 426 [56·9%] recorded as female; mean age 41·1 (SD 23·8) years) were admitted to hospital, with 749 720 patients (372 458 [49·7%] recorded as male and 378 670 [50·5%] as female) with severe mental illness. 5 102 055 patient deaths (2 862 383 [56·1%] recorded as male and 2 314 781 [45·4%] as female) and 67 485 deaths in patients with severe mental illness (39 099 [57·9%] recorded as male and 28 534 [42·3%] as female) were registered. The RR for all-cause mortality in patients with severe mental illness was 1·27 (95% CI 1·27-1·28) and the EMR was 2·52 (2·44-2·61) compared with non-psychiatric inpatients during the follow-up period. The all-cause RR was higher for females and for younger age groups; however, EMR was higher in those aged 30-59 years. The RR and EMR varied across the leading causes of death, sex, and age groups. We identified injuries (suicide, interpersonal violence, and road injuries) and cardiovascular disease (ischaemic heart disease) as having the highest EMR among those with severe mental illness. Data on ethnicity were not available.
INTERPRETATION
In contrast to studies from HICs, inpatients with severe mental illness in Brazil had high RR for idiopathic epilepsy, tuberculosis, HIV, and acute hepatitis, and no significant difference in mortality from cancer compared with inpatients without severe mental illness. These identified causes should be addressed as a priority to maximise mortality prevention among people with severe mental illness, especially in a middle-income country like Brazil that has low investment in mental health.
FUNDING
Bill and Melinda Gates Foundation, Fundação de Amparo a Pesquisa do Estado de Minas Gerais, FAPEMIG, and the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior-Brasil.

Identifiants

pubmed: 35964638
pii: S2215-0366(22)00237-1
doi: 10.1016/S2215-0366(22)00237-1
pmc: PMC9477749
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

771-781

Informations de copyright

Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests All other authors declare no competing interests.

Références

Healthc Manage Forum. 2017 Mar;30(2):111-116
pubmed: 28929889
Cien Saude Colet. 2018 Nov;23(11):3719-3733
pubmed: 30427444
PLoS One. 2011;6(5):e19590
pubmed: 21611123
Schizophr Bull. 1989;15(1):81-9
pubmed: 2717890
Rev Saude Publica. 2021 Apr 16;55:14
pubmed: 33886952
Can J Psychiatry. 2008 Nov;53(11):753-61
pubmed: 19087469
Cad Saude Publica. 2014 Jun;30(6):1195-206
pubmed: 25099043
PLoS One. 2016 Mar 24;11(3):e0152223
pubmed: 27010534
Acta Psychiatr Scand. 2013 Mar;127(3):195-201
pubmed: 23216065
Braz J Psychiatry. 2009 Mar;31(1):43-7
pubmed: 19506775
Arch Psychiatr Nurs. 2012 Jun;26(3):192-201
pubmed: 22633581
Int J Popul Data Sci. 2018 Nov 14;3(1):446
pubmed: 34095519
BMC Med Inform Decis Mak. 2021 Jun 2;21(1):175
pubmed: 34078366
Br J Psychiatry. 2011 Dec;199(6):441-2
pubmed: 22130744
World Psychiatry. 2011 Feb;10(1):52-77
pubmed: 21379357
BMC Med. 2013 Nov 26;11:250
pubmed: 24274053
Am J Psychiatry. 2004 Sep;161(9):1712-4
pubmed: 15337667
Gen Hosp Psychiatry. 2017 Mar - Apr;45:76-84
pubmed: 28274344
World Psychiatry. 2014 Jun;13(2):153-60
pubmed: 24890068
World Psychiatry. 2017 Jun;16(2):163-180
pubmed: 28498599
Addiction. 2021 Apr;116(4):725-742
pubmed: 32857457
BMJ Open. 2012 Apr 05;2(2):e000831
pubmed: 22492387
BMJ. 2013 May 21;346:f2539
pubmed: 23694688
Dtsch Arztebl Int. 2019 Jun 10;116(23-24):405-411
pubmed: 31366432
Epilepsia. 2005;46 Suppl 11:28-32
pubmed: 16393175
J Psychiatr Res. 2022 May;149:97-105
pubmed: 35259666
J Gen Intern Med. 2008 Oct;23(10):1571-5
pubmed: 18649108
Curr Psychiatry Rep. 2017 May;19(5):28
pubmed: 28425023
JAMA Psychiatry. 2015 Dec;72(12):1172-81
pubmed: 26509694
JAMA Psychiatry. 2015 Apr;72(4):334-41
pubmed: 25671328
Epilepsia. 2005;46 Suppl 11:33-5
pubmed: 16393176
Psychiatr Serv. 1997 Sep;48(9):1181-5
pubmed: 9285980
Rev Saude Publica. 2017 Aug 17;51:74
pubmed: 28832753
Lancet. 2016 Apr 16;387(10028):1672-85
pubmed: 26454360
Cien Saude Colet. 2018 Jun;23(6):1751-1762
pubmed: 29972484
Br J Psychiatry. 2017 Sep;211(3):175-181
pubmed: 28684403
PLoS One. 2013;8(1):e55176
pubmed: 23372832
Psychol Med. 2021 Jan;51(2):320-328
pubmed: 31775914
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Acta Psychiatr Scand. 2019 Sep;140(3):244-264
pubmed: 31325315

Auteurs

Ana Paula Souto Melo (APS)

Universidade Federal de São João Del Rei, São João del-Rei, Brazil; Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Ilse N Dippenaar (IN)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Sarah Charlotte Johnson (SC)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Nicole Davis Weaver (ND)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Francisco de Assis Acurcio (F)

Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Centro Colaborador do SUS para Avaliação de Tecnologias e Excelência em Saúde, Belo Horizonte, Brazil.

Deborah Carvalho Malta (DC)

Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Antônio Luiz P Ribeiro (ALP)

Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Telehealth Center and Cardiology Service, Hospital das Clínicas, and Department of Internal Medicine, Faculdade de Medicina, Belo Horizonte, Brazil.

Augusto Afonso Guerra Júnior (AAG)

Universidade Federal de Minas Gerais, Belo Horizonte, Brazil; Centro Colaborador do SUS para Avaliação de Tecnologias e Excelência em Saúde, Belo Horizonte, Brazil.

Eve E Wool (EE)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA.

Mohsen Naghavi (M)

Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, USA; Department of Health Metrics Sciences, University of Washington, Seattle, WA, USA. Electronic address: nagham@uw.edu.

Mariangela Leal Cherchiglia (ML)

Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH